annual retained earnings:
$9.76B+$535.43M(+5.80%)Summary
- As of today (August 20, 2025), GSK annual retained earnings is $9.76 billion, with the most recent change of +$535.43 million (+5.80%) on December 31, 2024.
- During the last 3 years, GSK annual retained earnings has fallen by -$3.50 billion (-26.39%).
- GSK annual retained earnings is now -41.49% below its all-time high of $16.69 billion, reached on December 31, 2006.
Performance
GSK Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$12.07B+$1.32B(+12.30%)Summary
- As of today (August 20, 2025), GSK quarterly retained earnings is $12.07 billion, with the most recent change of +$1.32 billion (+12.30%) on June 30, 2025.
- Over the past year, GSK quarterly retained earnings has increased by +$1.21 billion (+11.17%).
- GSK quarterly retained earnings is now -23.14% below its all-time high of $15.70 billion, reached on June 30, 2007.
Performance
GSK quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GSK Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.8% | +11.2% |
| 3 y3 years | -26.4% | +1.3% |
| 5 y5 years | +15.5% | +48.1% |
GSK Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.4% | +30.7% | at high | +316.9% |
| 5 y | 5-year | -26.4% | +30.7% | -4.7% | +316.9% |
| alltime | all time | -41.5% | +217.3% | -23.1% | +235.5% |
GSK Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $12.07B(+12.3%) |
| Mar 2025 | - | $10.75B(+9.9%) |
| Dec 2024 | $9.76B(+5.8%) | $9.78B(-10.7%) |
| Sep 2024 | - | $10.96B(+0.9%) |
| Jun 2024 | - | $10.86B(+8.4%) |
| Mar 2024 | - | $10.02B(+8.6%) |
| Dec 2023 | $9.23B(+23.5%) | $9.22B(+7.7%) |
| Sep 2023 | - | $8.56B(+5.8%) |
| Jun 2023 | - | $8.10B(+15.6%) |
| Mar 2023 | - | $7.00B(+32.6%) |
| Dec 2022 | $7.47B(-43.7%) | $5.28B(+82.4%) |
| Sep 2022 | - | $2.89B(-75.7%) |
| Jun 2022 | - | $11.92B(-5.9%) |
| Mar 2022 | - | $12.66B(+18.1%) |
| Dec 2021 | $13.26B(+12.8%) | $10.72B(+2.6%) |
| Sep 2021 | - | $10.45B(+2.3%) |
| Jun 2021 | - | $10.21B(+10.9%) |
| Mar 2021 | - | $9.21B(+0.0%) |
| Dec 2020 | $11.76B(+39.2%) | $9.21B(+1.4%) |
| Sep 2020 | - | $9.08B(+11.3%) |
| Jun 2020 | - | $8.15B(+3.7%) |
| Mar 2020 | - | $7.86B(+32.3%) |
| Dec 2019 | $8.45B(-2403.9%) | $5.94B(-8.2%) |
| Sep 2019 | - | $6.47B(-282.1%) |
| Jun 2019 | - | -$3.55B(+11.7%) |
| Mar 2019 | - | -$3.18B(-7.7%) |
| Dec 2018 | -$366.80M(-94.1%) | -$3.45B(+27.1%) |
| Sep 2018 | - | -$2.71B(-22.6%) |
| Jun 2018 | - | -$3.50B(-60.6%) |
| Mar 2018 | - | -$8.90B(+1.7%) |
| Dec 2017 | -$6.26B(+43.0%) | -$8.75B(+21.9%) |
| Sep 2017 | - | -$7.18B(-5.7%) |
| Jun 2017 | - | -$7.62B(+24.4%) |
| Mar 2017 | - | -$6.12B(-7.6%) |
| Dec 2016 | -$4.38B(-757.1%) | -$6.62B(-22.0%) |
| Sep 2016 | - | -$8.49B(+3.7%) |
| Jun 2016 | - | -$8.19B(+54.0%) |
| Mar 2016 | - | -$5.32B(+156.9%) |
| Dec 2015 | $666.20M(-289.9%) | -$2.07B(+101.7%) |
| Sep 2015 | - | -$1.03B(-217.3%) |
| Jun 2015 | - | $874.31M(-46.7%) |
| Mar 2015 | - | $1.64B(-150.8%) |
| Dec 2014 | -$350.83M(-107.7%) | -$3.23B(+67.0%) |
| Sep 2014 | - | -$1.93B(+618.2%) |
| Jun 2014 | - | -$269.10M(-133.8%) |
| Mar 2014 | - | $795.63M(-47.2%) |
| Dec 2013 | $4.57B(+13.0%) | $1.51B(-821.9%) |
| Sep 2013 | - | -$208.54M(-133.0%) |
| Jun 2013 | - | $631.52M(-67.9%) |
| Mar 2013 | - | $1.97B(+89.8%) |
| Dec 2012 | $4.05B(-50.1%) | $1.04B(-40.1%) |
| Sep 2012 | - | $1.73B(-45.6%) |
| Jun 2012 | - | $3.18B(-49.6%) |
| Mar 2012 | - | $6.31B(+21.6%) |
| Dec 2011 | $8.11B | $5.19B(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $4.91B(-32.2%) |
| Jun 2011 | - | $7.24B(-9.6%) |
| Mar 2011 | - | $8.01B(+8.6%) |
| Dec 2010 | $10.38B(-21.3%) | $7.38B(-20.0%) |
| Sep 2010 | - | $9.22B(+25.6%) |
| Jun 2010 | - | $7.34B(-29.1%) |
| Mar 2010 | - | $10.36B(+1.3%) |
| Dec 2009 | $13.19B(+41.8%) | $10.22B(+12.1%) |
| Sep 2009 | - | $9.12B(+30.1%) |
| Jun 2009 | - | $7.01B(+5.8%) |
| Mar 2009 | - | $6.63B(-2.1%) |
| Dec 2008 | $9.30B(-41.8%) | $6.77B(-7.3%) |
| Sep 2008 | - | $7.30B(-13.9%) |
| Jun 2008 | - | $8.48B(-25.2%) |
| Mar 2008 | - | $11.34B(-11.9%) |
| Dec 2007 | $16.00B(-4.1%) | $12.87B(-7.7%) |
| Sep 2007 | - | $13.94B(-11.2%) |
| Jun 2007 | - | $15.70B(+10.8%) |
| Mar 2007 | - | $14.17B(+3.9%) |
| Dec 2006 | $16.69B(+36.1%) | $13.64B(+5.0%) |
| Sep 2006 | - | $12.99B(+4.8%) |
| Jun 2006 | - | $12.40B(+4.0%) |
| Mar 2006 | - | $11.92B(+24.2%) |
| Dec 2005 | $12.26B(+4.6%) | $9.59B(-0.9%) |
| Sep 2005 | - | $9.68B(+7.6%) |
| Jun 2005 | - | $9.00B(+0.1%) |
| Mar 2005 | - | $8.99B(-0.2%) |
| Dec 2004 | $11.72B(+16.8%) | $9.01B(+27.9%) |
| Sep 2004 | - | $7.05B(-6.4%) |
| Jun 2004 | - | $7.53B(+23.1%) |
| Mar 2004 | - | $6.11B(-15.3%) |
| Dec 2003 | $10.03B(+38.3%) | $7.22B(-2.8%) |
| Sep 2003 | - | $7.43B(+10.6%) |
| Jun 2003 | - | $6.72B(+20.3%) |
| Mar 2003 | - | $5.58B(+17.6%) |
| Dec 2002 | $7.26B(-9.3%) | $4.75B(+5.5%) |
| Sep 2002 | - | $4.50B(-6.5%) |
| Jun 2002 | - | $4.81B(-9.6%) |
| Mar 2002 | - | $5.32B(-6.9%) |
| Dec 2001 | $8.00B(-8.2%) | $5.72B(-19.8%) |
| Sep 2001 | - | $7.13B(+5.0%) |
| Jun 2001 | - | $6.79B(+8.8%) |
| Mar 2001 | - | $6.24B(-2.1%) |
| Dec 2000 | $8.72B(+49.2%) | $6.38B(+946.0%) |
| Dec 1999 | $5.85B(+443.0%) | - |
| Jun 1999 | - | $609.50M(-7.4%) |
| Dec 1998 | $1.08B(-113.5%) | - |
| Jun 1998 | - | $658.43M(-89.9%) |
| Dec 1997 | -$7.96B(-4.3%) | - |
| Dec 1996 | -$8.33B(+3.2%) | - |
| Dec 1995 | -$8.07B(<-9900.0%) | - |
| Jun 1995 | - | $6.54B |
| Jun 1994 | $0.00(-100.0%) | - |
| Jun 1993 | $5.44B(+4.3%) | - |
| Jun 1992 | $5.22B(+33.0%) | - |
| Jun 1991 | $3.92B | - |
FAQ
- What is GSK plc annual retained earnings?
- What is the all time high annual retained earnings for GSK plc?
- What is GSK plc annual retained earnings year-on-year change?
- What is GSK plc quarterly retained earnings?
- What is the all time high quarterly retained earnings for GSK plc?
- What is GSK plc quarterly retained earnings year-on-year change?
What is GSK plc annual retained earnings?
The current annual retained earnings of GSK is $9.76B
What is the all time high annual retained earnings for GSK plc?
GSK plc all-time high annual retained earnings is $16.69B
What is GSK plc annual retained earnings year-on-year change?
Over the past year, GSK annual retained earnings has changed by +$535.43M (+5.80%)
What is GSK plc quarterly retained earnings?
The current quarterly retained earnings of GSK is $12.07B
What is the all time high quarterly retained earnings for GSK plc?
GSK plc all-time high quarterly retained earnings is $15.70B
What is GSK plc quarterly retained earnings year-on-year change?
Over the past year, GSK quarterly retained earnings has changed by +$1.21B (+11.17%)